Atlas Trials

Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia

Clinical trial NCT00004327 · COMPLETED

Trial details

NCT number
NCT00004327
Sponsor
National Center for Research Resources (NCRR)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hereditary Hemorrhagic TelangiectasiaEctasia
Start date
1995-01-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.